ArticleBriefings in bioinformatics2026
EPINTLM: enhancer-promoter prediction with pretrained k-mer embeddings and residual cross-attention.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Enhancer-promoter interactions (EPIs) play an important role in gene regulation, yet experimental mapping remains costly and limited in coverage. As a result, computational approaches are commonly evaluated under curated benchmark datasets, which pose challenges related to long-range sequence modeling, multimodal feature integration, and reproducible preprocessing. In this study, we present EPINTLM (Enhancer-Promoter Interaction Nucleotide Transformer Large Model), a deep learning framework designed to investigate architectural strategies for EPI prediction under standardized benchmark settings. EPINTLM integrates DNA sequence representations and genomic features by leveraging pretrained k-mer embeddings from the Nucleotide Transformer and explicitly modeling intra- and inter-sequence dependencies through residual self-attention and bidirectional cross-attention. We additionally introduce a unified preprocessing pipeline to improve training efficiency and reproducibility, and perform post hoc motif analysis to provide limited interpretability of learned sequence patterns. Evaluated on a widely used benchmark across six human cell lines, EPINTLM achieves competitive area under the receiver operating characteristic curve (AUROC) and area under the precision-recall curve (AUPR) performance relative to existing methods, with ablation studies highlighting the contributions of cross-attention and residual aggregation. These results demonstrate the utility of explicit cross-attention designs for paired regulatory sequence modeling within current benchmark constraints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.